Bone Biologics (BBLG) Competitors $3.02 -0.01 (-0.33%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$3.02 +0.00 (+0.17%) As of 07/25/2025 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BBLG vs. STSS, QNRX, NDRA, CHEK, BLAC, HSCS, XAGE, AMIX, TIVC, and VEROShould you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Sharps Technology (STSS), Quoin Pharmaceuticals (QNRX), ENDRA Life Sciences (NDRA), Check-Cap (CHEK), Bellevue Life Sciences Acquisition (BLAC), HeartSciences (HSCS), Longevity Health (XAGE), Autonomix Medical (AMIX), Tivic Health Systems (TIVC), and Venus Concept (VERO). These companies are all part of the "medical equipment" industry. Bone Biologics vs. Its Competitors Sharps Technology Quoin Pharmaceuticals ENDRA Life Sciences Check-Cap Bellevue Life Sciences Acquisition HeartSciences Longevity Health Autonomix Medical Tivic Health Systems Venus Concept Sharps Technology (NASDAQ:STSS) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment. Does the media refer more to STSS or BBLG? In the previous week, Sharps Technology and Sharps Technology both had 1 articles in the media. Sharps Technology's average media sentiment score of 1.89 beat Bone Biologics' score of 1.87 indicating that Sharps Technology is being referred to more favorably in the media. Company Overall Sentiment Sharps Technology Very Positive Bone Biologics Very Positive Is STSS or BBLG more profitable? Sharps Technology's return on equity of -98.77% beat Bone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Sharps TechnologyN/A -98.77% -53.85% Bone Biologics N/A -130.21%-119.39% Do insiders & institutionals hold more shares of STSS or BBLG? 17.2% of Sharps Technology shares are owned by institutional investors. Comparatively, 34.3% of Bone Biologics shares are owned by institutional investors. 1.5% of Sharps Technology shares are owned by insiders. Comparatively, 6.1% of Bone Biologics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, STSS or BBLG? Sharps Technology has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500. Comparatively, Bone Biologics has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Which has better valuation and earnings, STSS or BBLG? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSharps TechnologyN/AN/A-$9.30M-$1.88 thousand0.00Bone BiologicsN/AN/A-$4.11MN/AN/A SummarySharps Technology beats Bone Biologics on 4 of the 7 factors compared between the two stocks. Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBLG vs. The Competition Export to ExcelMetricBone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.65M$3.06B$5.69B$9.50BDividend YieldN/A2.37%4.58%4.01%P/E RatioN/A21.1828.1020.05Price / SalesN/A288.50432.4490.07Price / CashN/A42.7636.2258.56Price / Book0.368.378.665.87Net Income-$4.11M-$55.19M$3.25B$258.55M7 Day Performance5.59%5.88%4.23%3.74%1 Month Performance-27.40%17.33%10.52%11.75%1 Year Performance-74.71%4.42%34.41%18.03% Bone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBLGBone Biologics0.7272 of 5 stars$3.02-0.3%N/A-75.9%$1.65MN/A0.002STSSSharps Technology0.9745 of 5 stars$6.09-3.5%N/AN/A$6.21MN/A0.003Gap UpQNRXQuoin Pharmaceuticals1.6581 of 5 stars$8.35-2.1%N/A-62.7%$4.93MN/A-0.174Gap DownNDRAENDRA Life Sciences3.1806 of 5 stars$6.50+0.9%$50.00+669.2%-99.9%$4.89MN/A-0.0420Positive NewsGap UpCHEKCheck-Cap0.9375 of 5 stars$0.77+1.7%N/A-62.9%$4.49MN/A-0.2680BLACBellevue Life Sciences AcquisitionN/A$1.06+6.0%N/A-90.6%$4.28MN/A0.00N/AHigh Trading VolumeHSCSHeartSciences2.5914 of 5 stars$3.88-3.7%$13.00+235.1%+5.1%$4.19M$20K-0.5210News CoverageEarnings ReportAnalyst UpgradeXAGELongevity HealthN/A$4.16+4.3%N/AN/A$4.18M$560.67K0.0014Gap DownAMIXAutonomix Medical2.9724 of 5 stars$1.39-24.0%$16.50+1,087.1%-94.2%$3.86MN/A-0.191Positive NewsAnalyst UpgradeGap DownHigh Trading VolumeTIVCTivic Health Systems1.2434 of 5 stars$4.20+2.9%N/A-39.6%$3.70M$780K0.0010VEROVenus Concept0.8816 of 5 stars$2.49-0.4%N/A-55.8%$3.54M$64.83M-0.03410Positive News Related Companies and Tools Related Companies STSS Alternatives QNRX Alternatives NDRA Alternatives CHEK Alternatives BLAC Alternatives HSCS Alternatives XAGE Alternatives AMIX Alternatives TIVC Alternatives VERO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBLG) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBLG Stock Alerts